Sarepta Therapeutics Newsroom

RBC Capital Remains a Buy on Sarepta Therapeutics (SRPT)

TipRanks09:46 · Ratings

Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%

Seeking Alpha01:16

Sarepta Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones00:37 · Ratings

SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies

Zacks 00:00

Wall Street Analysts Think Sarepta Therapeutics (SRPT) Could Surge 42.11%: Read This Before Placing a Bet

Zacks Nov 27 22:05

Oppenheimer Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Maintains Target Price $215

Futu NewsNov 27 21:31 · Ratings

Piper Sandler Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Cuts Target Price to $182

Futu NewsNov 27 21:31 · Ratings

TD Cowen Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Maintains Target Price $203

Futu NewsNov 27 21:31 · Ratings

A Quick Look at Today's Ratings for Sarepta Therapeutics(SRPT.US), With a Forecast Between $182 to $217

Futu NewsNov 27 21:00 · Ratings

Sarepta Therapeutics (SRPT) Gets a Buy From TD Cowen

TipRanksNov 27 20:36 · Ratings

Sarepta Therapeutics Receives Buy Rating From Gil Blum: Strategic Partnerships and Financial Stability Highlight Growth Potential

TipRanksNov 27 19:05 · Ratings

US stocks mining | Nuclear energy stocks collectively rise! CEG's annual increase is nearly 130%; aerospace stocks celebrate together! SpaceX's formidable rival Rocket Lab has surged over 360% this year.

Hundred-billion collaboration agreement finalized! Biotechnology company sarepta therapeutics surged nearly 14% overnight, approaching a three-month high; Medical reimbursement limit increased! Medical diagnostic company exact sciences rose 9% last night.

Futu NewsNov 27 18:43

Needham Maintains Buy on Sarepta Therapeutics, Lowers Price Target to $202

BenzingaNov 27 18:40 · Ratings

Sarepta Therapeutics Analyst Ratings

BenzingaNov 27 18:37 · Ratings

Sarepta Therapeutics: Strategic Expansion and Robust Pipeline Justify Buy Rating and $217 Price Target

TipRanksNov 27 18:26 · Ratings

Express News | Sarepta Therapeutics Inc : Piper Sandler Cuts Target Price to $182 From $200

BreakingsNov 27 15:56

Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM

Seeking AlphaNov 27 03:01

Trending Stocks Today | CIMG Soars 138.09%

November 26th - US stocks trending in regular trading hours.Gainers: $CIMG(IMG.US)$ surges 138.09% to $1.5 with a turnover of $76.79 million. $T Stamp(IDAI.US)$ shoots up 83.33% to $0.33 with a

Futu NewsNov 27 03:00

Sector Update: Health Care Stocks Advance Tuesday Afternoon

MT NewswiresNov 27 02:49

Sector Update: Health Care

MT NewswiresNov 27 02:31